Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration
Advertisement
Evotec OAI AG and Rib-X Pharmaceuticals, Inc., announced the formation of a medicinal chemistry partnership.
Scientists from Rib-X and Evotec OAI will collaborate on several research programmes. Evotec OAI will be utilising its state-of-the-art integrated medicinal chemistry and parallel synthesis platform to facilitate Rib-X's efforts to identify novel antibiotics for clinical development.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.